Shanghai Pharma targets Aussie vitamin maker

The Chinese pharmaceutical firm offers $238 million to take Vitaco private, in the latest example of China’s huge interest in clean and green food products.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES